FIELD: biotechnology.
SUBSTANCE: invention relates to cellular biology and biotechnology, in particular to a method for producing erythrocytes, to erythrocytes and a pharmaceutical composition. Method includes swelling erythrocytes using a first hypotonic solution, which results in erythrocytes having osmolality of 250–200 mOsm/kg. Method includes further swelling of the erythrocytes without reaching lysis, using a second hypotonic solution which is more hypotonic than the first hypotonic solution and which results in the erythrocytes having osmolality of 200–170 mOsm/kg. Further, the erythrocytes are concentrated and the concentrated erythrocytes are brought into contact with a lysing solution containing one or more substances of pharmaceutical interest, which results in the erythrocytes having osmolality of 150–110 mOsm/kg. Further, a sealing solution is added to obtain an erythrocyte population, which is characterised in that the percentage of phosphatidylserine formed by the erythrocytes, which is measured in annexin V assay, is less than 10 % and the amount of lactate formed for every 106 erythrocytes is 0.100 nmol/h. Resulting erythrocytes can be used as part of a pharmaceutical composition for use in therapeutic treatment.
EFFECT: invention makes it possible to obtain erythrocytes loaded with one or more substances of pharmaceutical interest, avoiding mechanical stress and simplifying the sealing step.
18 cl, 4 dwg, 8 tbl, 9 ex
Title |
Year |
Author |
Number |
DEVICE AND SET FOR ERYTHROCYTE ENCAPSULATION OF AT LEAST ONE COMPOUND FOR THERAPEUTIC AND DIAGNOSTIC APPLICATION |
2011 |
- Mambrini Dzhovanni
- Serafini Sonya
|
RU2595844C2 |
ARGININE DEIMINASE ENCAPSULATED IN ERYTHROCYTES, AND THEIR USE IN TREATMENT OF CANCER AND ARGINASE-1 DEFICIENCY |
2018 |
- Dufour, Emmanuelle
- Blanc, Manuel
- Meyzaud, Aurelien
|
RU2773220C2 |
METHOD FOR INCLUDING BIOLOGICALLY ACTIVE COMPONENTS IN ERYTHROCYTES BY METHOD OF FLOW HYPOOSMOTIC DIALYSIS |
2021 |
- Ataullakhanov Fazoil Inoyatovich
- Zejnalov Azer Mamedovich
- Sinauridze Elena Ivanovna
- Koleva Larisa
|
RU2791817C1 |
PHARMACEUTICAL COMPOSITION COMPRISING ERYTHROCYTES CONTAINING ENZYME DEPENDENT ON PYRIDOXALPHOSPHATE AND COFACTOR THEREOF |
2015 |
- Godfrin, Yann
- Bourgeaux, Vanessa
- Gay, Fabien
- Cortese, Thomas
|
RU2744659C2 |
PHARMACEUTICAL COMPOSITION CONTAINING ERYTHROCYTES IN WHICH AN ENZYME DEPENDENT ON PYRIDOXALPHOSPHATE IS ENCLOSED, AND COFACTOR THEREOF |
2015 |
- Godfren Yann
- Borzho Vanessa
- Ge Faben
- Kortez Toma
|
RU2697086C2 |
METHOD OF TREATING CANCER IN A MAMMAL, INCLUDING A HUMAN, USING METHIONINE AND ASPARAGINE DEPLETION |
2017 |
- Agera Karin
- Berle Villi
- Ge Faben
- Godfren Yan
|
RU2733389C2 |
METHOD FOR STABILIZING SUSPENSIONS OF RED BLOOD CELLS ENCAPSULATING ACTIVE INGREDIENT AND SUSPENSIONS OBTAINED |
2014 |
- Godfren Yann
- Borzho Vanessa
- Belli Zherom
|
RU2668688C2 |
SALINE SOLUTION FOR DRUG REDUCTION OR DILUTION |
2006 |
- Vehb Chandra A.
- Zerfas Dzhulija
|
RU2432157C2 |
MELATONIN-BASED SOLUTIONS AND POWDERS FOR THEIR PREPARATION |
2012 |
- Madzhi Loretta
- Kaponetti Dzhovanni
|
RU2646802C2 |
DEVICE FOR THE INCLUSION OF BIOLOGICALLY ACTIVE COMPONENTS IN RED BLOOD CELLS BY THE CONTINUOUS FLOW DIALYSIS METHOD |
2021 |
- Ataullakhanov Fazoil Inoyatovich
- Borsakova Daria Valerevna
- Bovt Elizaveta Andreevna
- Danielian Akop Dzhivanovich
- Zeinalov Azer Mamedovich
- Koleva Larisa
- Kushnir Nikita Sergeevich
- Protasov Evgenii Sergeevich
- Sinauridze Elena Ivanovna
- Suvorova Anna Sergeevna
|
RU2772209C1 |